Treatment results of nine patients with burkitt's lymphoma
β Scribed by Anger, B. ;Bunjes, D. ;Carbonell, F. ;Kurrle, E. ;Heimpel, H.
- Book ID
- 104721513
- Publisher
- Springer-Verlag
- Year
- 1986
- Weight
- 403 KB
- Volume
- 53
- Category
- Article
- ISSN
- 1432-0584
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract The results of a clinical trial in patients with generalized Burkitt's lymphoma using either multiple doses of cyclophosphamide or a cyclic, sequential regimen employing cylophosphamide, vincristine, methotrexate, and cytosine arabinoside (TRIKE) are reported. Of 42 evaluable patients 2
## Abstract A microβassay colony inhibition (CI) test has been developed for studying cellβmediated reactions against lymphoblastoid target cells. The assay makes use of the ability of the target cells, but not the effector cells, to grow in discrete colonies in semiβsolid medium. Peripheral blood
O n e hundred and ten previously untreated patients with Burkitt's lymphoma were studied prospectively over a period ranging from over 1 year to 5 years. Of 103 patients who were treated with cyclophosphamide as a single agent, 79 (77%) achieved complete remission. Vincristine plus methotrexate o r